When people who are overweight and obese stopped taking their weight-loss medications they regained weight faster than those who stopped a diet or exercise program, a new review has found. Weight loss medications containing semaglutide, the active ingredient in Ozempic and Wegovy, have taken off in popularity. But about half of people with obesity on…
In today’s fast-paced world, the rise in lifestyle-related diseases has become a major public health concern. Conditions like obesity, diabetes, hypertension, PCOD, and cardiovascular disorders are increasingly affecting people across all age groups. The root causes of these issues often stem from sedentary habits, poor diet, excessive stress, and inadequate sleep. These diseases not only…
IV hydration may have started as something you’d only see in a hospital room or a pro athlete’s locker, but in Texas, it has become a full-blown wellness movement. Across the Lone Star State, IV hydration and medical weight loss clinics are opening faster than new taco joints—minus the guilt, plus a vitamin boost. What…
By Andrew Silver SHANGHAI (Reuters) -Innovent Biologics’ newly launched weight-loss drug is making inroads in its home market of China, ramping up competition with its Western rivals as it pursues a marketing strategy that is gaining traction. Xinermei, launched in July, is the third once-weekly injectable GLP-1 weight management therapy available in China after Novo…
Summer in Britain has a way of unravelling even the best-laid health plans. Between the barbecues, the pub gardens, and the “just one more” holiday cocktails, weight loss often takes a back seat. But with autumn setting in, one GP says it’s the perfect time to stop making excuses and start regaining control. Dr Donald…
PENSACOLA, Fla. — High blood pressure can be deadly. Studies estimate half of all adults in the United States suffer from it. Doctors Madison Gilbert and Josie Blasius are ambulatory care pharmacists. They run the new hypertension clinic at Ascension Sacred Heart. Every day, they treat patients with high blood pressure. For the first time…
A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk. Hollie Adams | Reuters New trial data suggests Novo Nordisk‘s weight loss drug Wegovy edges out rival treatments on heart condition risk reduction, in good news for the Danish pharma giant as it…
Amgen Inc. (NASDAQ:AMGN) shares are trading lower on Wednesday, despite the company reporting second-quarter results that surpassed analyst expectations after markets closed on Tuesday. The US drug maker reported adjusted earnings of $6.02 per share, up 21% year over year, beating the consensus of $5.24. Amgen reported quarterly sales of $9.18 billion, up 9%, beating…